OTX-101 cyclosporine in moderate-to-severe corneal damage
A post-hoc analysis focused on patients with moderate-to-severe corneal staining in randomised trials.
doi: 10.1007/s00417-025-07054-7A post-hoc analysis focused on patients with moderate-to-severe corneal staining in randomised trials.
doi: 10.1007/s00417-025-07054-7